Androstane-3,17-diol,2-(4-morpholinyl)-16-(1-pyrrolidinyl)
- CAS NO.:119302-22-6
- Empirical Formula: C31H50N2O5
- Molecular Weight: 530.74
- Update Date: 2023-06-28 08:28:15
Properties of Androstane-3,17-diol,2-(4-morpholinyl)-16-(1-pyrrolidinyl)
Boiling point: | 583.9±50.0 °C(Predicted) |
Density | 1.17±0.1 g/cm3(Predicted) |
pka | 9.63±0.20(Predicted) |
Safety information for Androstane-3,17-diol,2-(4-morpholinyl)-16-(1-pyrrolidinyl)
Computed Descriptors for Androstane-3,17-diol,2-(4-morpholinyl)-16-(1-pyrrolidinyl)
New Products
SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION Azithromycin Imp D Azithromycin EP Impurity C Atracurium Besylate EP Impurity D Azithromycin EP Impurity B Azithromycin EP Impurity O Cetirizine Glycerol Ester Impurity HydrochlorideRelated products of tetrahydrofuran
RocuroniuM BroMide IMpurity 15
(2b,3a,5a,16b,17b)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,5,6,7,8,9,10,11,12,13,15,16-dodecahydro-4H-cyclopenta[a]phenanthren-17(14H)-one
2-Pyrrolidinyl-3-acetyl Desmorpholinylrocuronium Bromide
Androstan-17-one,3-[[(4-methylphenyl)sulfonyl]oxy]-,(3,5)-
Epiandrosterone
Rocuronium bromide Impurity 14
2a,3a,16a,17a-Diepoxy-17b-acetoxy-5a-androstane
You may like
-
Atracurium Besylate EP Impurity CView Details
86293-35-8 -
Atracurium Besylate EP Impurity DView Details
87046-72-8 -
Azithromycin EP Impurity BView Details
307974-61-4 -
Azithromycin EP Impurity CView Details
620169-47-3 -
Azithromycin EP Impurity OView Details
763924-54-5 -
Azithromycin Imp DView Details
612069-26-8 -
Ceftaroline fosamil Acetate HydrateView Details
400827-55-6 -
Cetirizine Glycerol Ester Impurity HydrochlorideView Details
1243652-36-9
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.